Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.
D000172:Acromegaly / Q000097:blood*; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001120:Arginine / Q000008:administration & dosage; D003920:Diabetes Mellitus / Q000097:blood*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005934:Glucagon / Q000097:blood*; D005947:Glucose / Q000008:administration & dosage; D005951:Glucose Tolerance Test; D013006:Growth Hormone / Q000097:blood*; D013007:Growth Hormone-Releasing Hormone / Q000037:antagonists & inhibitors*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007018:Hypopituitarism / Q000097:blood*; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood*; D008297:Male; D008722:Methods; D008875:Middle Aged; D011863:Radioimmunoassay
D005230:Fatty Acids, Nonesterified; D007328:Insulin; D013006:Growth Hormone; D005934:Glucagon; D013007:Growth Hormone-Releasing Hormone; D001120:Arginine; D005947:Glucose; D006854:Hydrocortisone